| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mutation | 23 | 2024 | 4132 | 1.500 |
Why?
|
| Molecular Dynamics Simulation | 10 | 2014 | 255 | 1.290 |
Why?
|
| Proteins | 5 | 2024 | 786 | 1.280 |
Why?
|
| Adenocarcinoma | 3 | 2023 | 1194 | 1.160 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2022 | 412 | 1.100 |
Why?
|
| Esophageal Neoplasms | 3 | 2023 | 332 | 1.070 |
Why?
|
| Receptor, Notch1 | 5 | 2023 | 94 | 1.060 |
Why?
|
| Cell Membrane | 10 | 2014 | 668 | 1.030 |
Why?
|
| KCNQ Potassium Channels | 1 | 2023 | 7 | 0.910 |
Why?
|
| Protein Folding | 2 | 2024 | 287 | 0.900 |
Why?
|
| Models, Molecular | 9 | 2020 | 1296 | 0.890 |
Why?
|
| Clonal Evolution | 1 | 2023 | 15 | 0.890 |
Why?
|
| Signal Transduction | 8 | 2020 | 3373 | 0.880 |
Why?
|
| Carcinogenesis | 4 | 2023 | 211 | 0.870 |
Why?
|
| Epithelium | 4 | 2023 | 325 | 0.870 |
Why?
|
| Caenorhabditis elegans | 2 | 2015 | 230 | 0.840 |
Why?
|
| Metabolomics | 1 | 2022 | 75 | 0.820 |
Why?
|
| Skin Neoplasms | 3 | 2023 | 579 | 0.810 |
Why?
|
| Clone Cells | 6 | 2022 | 214 | 0.810 |
Why?
|
| Neoplasms | 6 | 2022 | 3035 | 0.770 |
Why?
|
| Leiomyomatosis | 1 | 2021 | 12 | 0.760 |
Why?
|
| DNA Repair | 2 | 2021 | 362 | 0.750 |
Why?
|
| Membrane Proteins | 9 | 2022 | 1215 | 0.740 |
Why?
|
| Epithelial Cells | 3 | 2021 | 688 | 0.730 |
Why?
|
| Myeloproliferative Disorders | 1 | 2022 | 132 | 0.730 |
Why?
|
| Stem Cells | 3 | 2020 | 372 | 0.710 |
Why?
|
| Germ Cells | 2 | 2020 | 130 | 0.650 |
Why?
|
| Hematologic Neoplasms | 1 | 2022 | 342 | 0.640 |
Why?
|
| DNA Damage | 1 | 2019 | 371 | 0.600 |
Why?
|
| Models, Biological | 7 | 2020 | 1763 | 0.580 |
Why?
|
| Uterine Neoplasms | 1 | 2021 | 245 | 0.560 |
Why?
|
| Software | 2 | 2020 | 665 | 0.550 |
Why?
|
| Models, Genetic | 2 | 2019 | 944 | 0.540 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2022 | 788 | 0.530 |
Why?
|
| Immediate-Early Proteins | 3 | 2013 | 165 | 0.510 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 635 | 0.510 |
Why?
|
| Selection, Genetic | 1 | 2019 | 509 | 0.500 |
Why?
|
| Epidermis | 3 | 2020 | 102 | 0.490 |
Why?
|
| Organogenesis | 1 | 2014 | 50 | 0.470 |
Why?
|
| Homeostasis | 2 | 2018 | 413 | 0.470 |
Why?
|
| Peptides | 3 | 2012 | 646 | 0.450 |
Why?
|
| Receptors, Cell Surface | 2 | 2011 | 289 | 0.440 |
Why?
|
| Bacterial Proteins | 4 | 2013 | 887 | 0.430 |
Why?
|
| Lopinavir | 1 | 2012 | 5 | 0.430 |
Why?
|
| HIV Protease | 1 | 2012 | 10 | 0.420 |
Why?
|
| HIV Protease Inhibitors | 1 | 2012 | 21 | 0.420 |
Why?
|
| Ritonavir | 1 | 2012 | 12 | 0.420 |
Why?
|
| Membrane Microdomains | 1 | 2012 | 54 | 0.420 |
Why?
|
| Protein Conformation | 5 | 2012 | 887 | 0.410 |
Why?
|
| Catalytic Domain | 1 | 2012 | 156 | 0.410 |
Why?
|
| Computer Simulation | 9 | 2024 | 1097 | 0.400 |
Why?
|
| Protein Structure, Secondary | 10 | 2013 | 332 | 0.390 |
Why?
|
| Water | 2 | 2012 | 283 | 0.390 |
Why?
|
| Esophagus | 3 | 2022 | 106 | 0.390 |
Why?
|
| Estrogen Receptor alpha | 1 | 2012 | 147 | 0.380 |
Why?
|
| Genotype | 2 | 2017 | 1848 | 0.370 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2023 | 1096 | 0.370 |
Why?
|
| Lipid Bilayers | 7 | 2012 | 136 | 0.360 |
Why?
|
| Escherichia coli Proteins | 1 | 2011 | 183 | 0.360 |
Why?
|
| Humans | 28 | 2024 | 89063 | 0.350 |
Why?
|
| Computational Biology | 4 | 2024 | 542 | 0.340 |
Why?
|
| Genomics | 2 | 2024 | 761 | 0.270 |
Why?
|
| Protein Binding | 6 | 2024 | 1487 | 0.270 |
Why?
|
| Animals | 19 | 2023 | 27317 | 0.260 |
Why?
|
| Cell Proliferation | 4 | 2021 | 1650 | 0.250 |
Why?
|
| Mice | 12 | 2023 | 11737 | 0.240 |
Why?
|
| Macrophages | 3 | 2024 | 571 | 0.240 |
Why?
|
| Thermodynamics | 4 | 2012 | 311 | 0.230 |
Why?
|
| KCNQ3 Potassium Channel | 1 | 2023 | 2 | 0.230 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2023 | 4 | 0.230 |
Why?
|
| Breast Neoplasms | 2 | 2021 | 3000 | 0.230 |
Why?
|
| Smad4 Protein | 1 | 2023 | 24 | 0.230 |
Why?
|
| Cell Cycle | 3 | 2020 | 509 | 0.220 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2024 | 481 | 0.220 |
Why?
|
| Protein Stability | 2 | 2021 | 100 | 0.220 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2022 | 57 | 0.210 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2024 | 169 | 0.200 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2022 | 81 | 0.200 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 193 | 0.200 |
Why?
|
| Amino Acid Sequence | 8 | 2013 | 2062 | 0.200 |
Why?
|
| Lactic Acid | 1 | 2022 | 92 | 0.200 |
Why?
|
| Lymphatic Metastasis | 1 | 2023 | 502 | 0.190 |
Why?
|
| Fumarate Hydratase | 1 | 2021 | 6 | 0.190 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 43 | 0.190 |
Why?
|
| Arginine | 2 | 2012 | 138 | 0.190 |
Why?
|
| Molecular Sequence Data | 8 | 2013 | 3027 | 0.190 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2021 | 106 | 0.190 |
Why?
|
| Cell Survival | 2 | 2021 | 982 | 0.190 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2011 | 56 | 0.180 |
Why?
|
| Fibroblasts | 3 | 2022 | 755 | 0.180 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2020 | 61 | 0.180 |
Why?
|
| BRCA2 Protein | 1 | 2021 | 161 | 0.180 |
Why?
|
| Dictyostelium | 1 | 2020 | 43 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 1 | 2023 | 866 | 0.170 |
Why?
|
| Eyelids | 1 | 2019 | 23 | 0.170 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 64 | 0.170 |
Why?
|
| Mutagenesis | 1 | 2019 | 202 | 0.170 |
Why?
|
| Cyclic AMP | 1 | 2020 | 274 | 0.170 |
Why?
|
| Stromal Cells | 2 | 2018 | 151 | 0.160 |
Why?
|
| Osmoregulation | 1 | 2018 | 2 | 0.160 |
Why?
|
| Binding Sites | 3 | 2024 | 1117 | 0.160 |
Why?
|
| Homeodomain Proteins | 1 | 2022 | 556 | 0.160 |
Why?
|
| Systems Biology | 1 | 2018 | 44 | 0.150 |
Why?
|
| Cell Line | 1 | 2022 | 2495 | 0.150 |
Why?
|
| Female | 12 | 2021 | 46011 | 0.150 |
Why?
|
| Time Factors | 4 | 2021 | 5320 | 0.150 |
Why?
|
| Cell Lineage | 2 | 2020 | 291 | 0.150 |
Why?
|
| Lymph Nodes | 2 | 2022 | 548 | 0.140 |
Why?
|
| Simvastatin | 1 | 2017 | 105 | 0.140 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 117 | 0.140 |
Why?
|
| Protein Multimerization | 3 | 2013 | 175 | 0.130 |
Why?
|
| Gonads | 1 | 2015 | 19 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2017 | 616 | 0.130 |
Why?
|
| Herpesvirus 8, Human | 1 | 2015 | 11 | 0.130 |
Why?
|
| Sarcoma, Kaposi | 1 | 2015 | 18 | 0.130 |
Why?
|
| I-kappa B Kinase | 1 | 2015 | 41 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2017 | 259 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 3209 | 0.120 |
Why?
|
| Genome, Helminth | 1 | 2014 | 5 | 0.120 |
Why?
|
| Vulva | 1 | 2014 | 23 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 763 | 0.120 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2005 | 121 | 0.120 |
Why?
|
| Video Recording | 1 | 2015 | 203 | 0.120 |
Why?
|
| Apoptosis | 3 | 2015 | 1716 | 0.120 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2014 | 24 | 0.120 |
Why?
|
| Dexamethasone | 2 | 2013 | 344 | 0.120 |
Why?
|
| Receptors, Notch | 1 | 2014 | 123 | 0.110 |
Why?
|
| Hormone Antagonists | 1 | 2013 | 19 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 447 | 0.110 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2013 | 29 | 0.110 |
Why?
|
| Peptide Fragments | 2 | 2012 | 463 | 0.110 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 173 | 0.110 |
Why?
|
| Mifepristone | 1 | 2013 | 33 | 0.110 |
Why?
|
| Viral Proteins | 1 | 2015 | 301 | 0.110 |
Why?
|
| Movement | 2 | 2012 | 307 | 0.110 |
Why?
|
| Databases, Protein | 2 | 2010 | 51 | 0.110 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2014 | 113 | 0.110 |
Why?
|
| Alphaproteobacteria | 1 | 2013 | 5 | 0.110 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2012 | 17 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2022 | 1574 | 0.110 |
Why?
|
| Viral Fusion Proteins | 1 | 2012 | 10 | 0.110 |
Why?
|
| Vesicle-Associated Membrane Protein 2 | 1 | 2012 | 2 | 0.110 |
Why?
|
| Voltage-Gated Sodium Channels | 1 | 2013 | 17 | 0.110 |
Why?
|
| Membrane Fluidity | 1 | 2012 | 8 | 0.110 |
Why?
|
| Calcium Signaling | 1 | 2013 | 138 | 0.110 |
Why?
|
| Furans | 1 | 2012 | 16 | 0.110 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2012 | 11 | 0.110 |
Why?
|
| Mechanical Phenomena | 1 | 2012 | 15 | 0.110 |
Why?
|
| Phosphatidylcholines | 1 | 2012 | 48 | 0.110 |
Why?
|
| Enzyme Activators | 1 | 2012 | 14 | 0.110 |
Why?
|
| Thapsigargin | 1 | 2012 | 55 | 0.110 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2012 | 29 | 0.100 |
Why?
|
| Drug Resistance, Viral | 1 | 2012 | 48 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2016 | 1521 | 0.100 |
Why?
|
| MCF-7 Cells | 1 | 2012 | 114 | 0.100 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2013 | 131 | 0.100 |
Why?
|
| Escherichia coli | 2 | 2013 | 605 | 0.100 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2011 | 5 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 5 | 2014 | 740 | 0.100 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 96 | 0.100 |
Why?
|
| Integrin beta3 | 1 | 2011 | 32 | 0.100 |
Why?
|
| Models, Chemical | 1 | 2012 | 179 | 0.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2012 | 156 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 267 | 0.100 |
Why?
|
| ErbB Receptors | 1 | 2014 | 500 | 0.100 |
Why?
|
| Sirolimus | 1 | 2012 | 170 | 0.100 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2013 | 152 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 185 | 0.090 |
Why?
|
| Dengue | 1 | 2011 | 44 | 0.090 |
Why?
|
| Dengue Virus | 1 | 2011 | 43 | 0.090 |
Why?
|
| Lectins, C-Type | 1 | 2011 | 86 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2012 | 698 | 0.090 |
Why?
|
| Algorithms | 3 | 2015 | 1875 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2013 | 727 | 0.090 |
Why?
|
| Obesity | 1 | 2017 | 966 | 0.090 |
Why?
|
| Database Management Systems | 1 | 2010 | 41 | 0.090 |
Why?
|
| Internet | 2 | 2010 | 318 | 0.090 |
Why?
|
| Ion Channel Gating | 3 | 2013 | 325 | 0.090 |
Why?
|
| Pyridines | 1 | 2012 | 315 | 0.090 |
Why?
|
| Ultraviolet Rays | 2 | 2023 | 194 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 2752 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 382 | 0.090 |
Why?
|
| Mitochondria | 1 | 2013 | 553 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2012 | 1130 | 0.090 |
Why?
|
| Pyrimidines | 1 | 2012 | 372 | 0.090 |
Why?
|
| Ligands | 2 | 2007 | 443 | 0.080 |
Why?
|
| Islets of Langerhans | 1 | 2012 | 548 | 0.080 |
Why?
|
| Calcium | 1 | 2013 | 1172 | 0.080 |
Why?
|
| Cell Death | 2 | 2021 | 262 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2012 | 404 | 0.080 |
Why?
|
| Periplasmic Binding Proteins | 1 | 2007 | 25 | 0.070 |
Why?
|
| Insulin | 1 | 2012 | 1146 | 0.070 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 87 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2024 | 345 | 0.070 |
Why?
|
| Archaeal Proteins | 1 | 2006 | 18 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2012 | 312 | 0.070 |
Why?
|
| Ion Channels | 2 | 2022 | 246 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2021 | 638 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 2552 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 2347 | 0.060 |
Why?
|
| Crystallography, X-Ray | 3 | 2013 | 486 | 0.060 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 308 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2007 | 681 | 0.060 |
Why?
|
| Caspase 3 | 2 | 2013 | 162 | 0.060 |
Why?
|
| Chromosomal Instability | 1 | 2022 | 19 | 0.050 |
Why?
|
| Static Electricity | 2 | 2013 | 90 | 0.050 |
Why?
|
| Keratinocytes | 1 | 2023 | 146 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2362 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 1265 | 0.050 |
Why?
|
| Electron Spin Resonance Spectroscopy | 2 | 2015 | 317 | 0.050 |
Why?
|
| Homologous Recombination | 1 | 2021 | 52 | 0.050 |
Why?
|
| Forearm | 1 | 2020 | 31 | 0.050 |
Why?
|
| Diethylnitrosamine | 1 | 2020 | 7 | 0.050 |
Why?
|
| Receptor, Notch2 | 1 | 2020 | 6 | 0.050 |
Why?
|
| Male | 5 | 2021 | 42251 | 0.050 |
Why?
|
| ADAM10 Protein | 1 | 2020 | 7 | 0.050 |
Why?
|
| Thorax | 1 | 2020 | 77 | 0.040 |
Why?
|
| Leg | 1 | 2020 | 140 | 0.040 |
Why?
|
| Dimerization | 2 | 2014 | 143 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2021 | 511 | 0.040 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2020 | 93 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2021 | 277 | 0.040 |
Why?
|
| Cadherins | 1 | 2020 | 163 | 0.040 |
Why?
|
| Oscillometry | 1 | 2018 | 25 | 0.040 |
Why?
|
| Cell Division | 1 | 2020 | 696 | 0.040 |
Why?
|
| Inflammation | 1 | 2024 | 971 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2018 | 221 | 0.040 |
Why?
|
| Biological Transport | 1 | 2018 | 401 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2017 | 66 | 0.040 |
Why?
|
| Chemokine CCL21 | 1 | 2016 | 16 | 0.030 |
Why?
|
| Imidazoles | 1 | 2017 | 148 | 0.030 |
Why?
|
| Interleukin-7 | 1 | 2016 | 41 | 0.030 |
Why?
|
| Cellular Reprogramming | 1 | 2016 | 41 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 127 | 0.030 |
Why?
|
| Middle Aged | 3 | 2023 | 25863 | 0.030 |
Why?
|
| Melanoma, Experimental | 1 | 2016 | 104 | 0.030 |
Why?
|
| Piperazines | 1 | 2017 | 283 | 0.030 |
Why?
|
| Principal Component Analysis | 2 | 2006 | 160 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 2015 | 36 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 116 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 2015 | 54 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 285 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 82 | 0.030 |
Why?
|
| Imatinib Mesylate | 1 | 2015 | 127 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2016 | 244 | 0.030 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2015 | 108 | 0.030 |
Why?
|
| ras Proteins | 1 | 2015 | 130 | 0.030 |
Why?
|
| Caspase 7 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Mitochondrial Membranes | 1 | 2013 | 15 | 0.030 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2013 | 17 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2013 | 88 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 261 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2013 | 51 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 376 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2880 | 0.030 |
Why?
|
| Necrosis | 1 | 2013 | 209 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2013 | 261 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 397 | 0.030 |
Why?
|
| Pancreatic Hormones | 1 | 2012 | 15 | 0.030 |
Why?
|
| Porosity | 1 | 2012 | 59 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 783 | 0.030 |
Why?
|
| Membrane Fusion | 1 | 2012 | 37 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 459 | 0.030 |
Why?
|
| Pancreas, Exocrine | 1 | 2012 | 18 | 0.030 |
Why?
|
| Paraffin Embedding | 1 | 2012 | 78 | 0.030 |
Why?
|
| Cytokines | 1 | 2016 | 802 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 370 | 0.030 |
Why?
|
| Autopsy | 1 | 2012 | 122 | 0.030 |
Why?
|
| Cell Count | 1 | 2012 | 200 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 1108 | 0.020 |
Why?
|
| Phenotype | 1 | 2018 | 2439 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 323 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 277 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 393 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2013 | 479 | 0.020 |
Why?
|
| Transcriptome | 1 | 2016 | 628 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2011 | 99 | 0.020 |
Why?
|
| Temperature | 1 | 2012 | 400 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1012 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2012 | 473 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2010 | 94 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 412 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2010 | 117 | 0.020 |
Why?
|
| Rotation | 1 | 2010 | 91 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2012 | 295 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 19077 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2010 | 187 | 0.020 |
Why?
|
| Mammals | 1 | 2011 | 235 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 313 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 338 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 1310 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 255 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 26507 | 0.020 |
Why?
|
| Methanococcus | 1 | 2006 | 5 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 1363 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 2476 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 4040 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 2411 | 0.020 |
Why?
|
| Biomarkers | 1 | 2012 | 1755 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 3147 | 0.020 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2005 | 8 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2012 | 3717 | 0.020 |
Why?
|
| Anisotropy | 1 | 2005 | 63 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2005 | 96 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 2005 | 177 | 0.020 |
Why?
|
| Biophysics | 1 | 2005 | 153 | 0.020 |
Why?
|
| Computer Graphics | 1 | 2004 | 100 | 0.020 |
Why?
|
| Phosphates | 1 | 2005 | 160 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 418 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 2005 | 131 | 0.010 |
Why?
|
| Kinetics | 1 | 2006 | 1528 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 316 | 0.010 |
Why?
|
| Neurons | 1 | 2012 | 1580 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 2552 | 0.010 |
Why?
|
| Potassium Channels | 1 | 2005 | 343 | 0.010 |
Why?
|
| Child | 1 | 2012 | 7149 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 6288 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 9237 | 0.010 |
Why?
|